Xenova | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

552 results for “Xenova”

Trials

View all 365 →

XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer

157 participants · First posted Aug 9, 2005

Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids

117 participants · First posted Oct 14, 2005

Inova Cardiogenic Shock Registry (INOVA SHOCK)

3,000 participants · First posted Dec 20, 2017

Drugs

View all 67 →

Votumumab(Xenova Ltd.)

Herpes simplex vaccine (Xenova)

topoisomerase inhibitors (Xenova/University of Auckland)

Organizations

View all 55 →

Xenova Ltd.

United Kingdom

Genova

GENOVA, INC.

Japan

News

View all 65 →

Avacta Therapeutics Promotes Francis Wilson to Chief Scientific Officer to Lead pre|CISION Platform Development

Aenova Expands Irish Facility to Tackle Drug Bioavailability Challenge with Advanced Spray Drying Technology

Xenopax Demonstrates Superior Efficacy in Steroid-Refractory Acute GVHD Treatment

Page 1 of 56